WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 17'3701 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 25'0491 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 1'287  1'291  1'294  1'299  1'303  1'366  1'565  1'474 
Births 14  14  14  15  15  12  21  22 
Surviving infants 14  14  14  14  15  12  20  22 
Pop. less than 5 years 71  73  74  73  72  61  119  109 
Pop. less than 15 years 204  203  202  200  199  245  347  319 
Female 15-49 years 297  300  304  308  312  341  380  372 

Number of reported case

(Click for retrospective incidence data for Estonia)
Diphtheria
Japanese encephalitis
Measles 33 
Mumps 12  13  11  63 
Pertussis 55  149  478  1'295  629  503  87 
Polio*
Rubella 370 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Estonia)
Vaccine year result method % card seen                                                
BCG          96  97  99  97  97  100 
DTP1          96  96  96  96  97  96 
DTP3          94  94  93  94  95  93 
HepB_BD          96  96  16 
HepB3          93  94  94  94  95 
Hib3          94  94  93  94  95 
JapEnc         
MCV          94  94  94  95  95  93 
MCV2          92  94  95  95  96  89 
PCV1         
PCV3         
Pol3          94  94  93  94  95  93 
Rota1         
Rota_last         
Rubella1          94  94  94  95  95 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Estonia)
BCG 96  97  99  97  97  99 
DTP1 96  96  96  96  97  96 
DTP3 94  94  93  94  95  93 
HepB3 93  94  94  94  95 
HepB_BD 96  96  96  96  96 
Hib3 94  94  93  94  95 
MCV 94  94  94  95  95  93 
MCV2 92  94  95  95  96  89 
PCV3
Pol3 94  94  93  94  95  93 
Rota_last

Number of districts in the country 15  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1-5 days; Yes
DT 3, 4.5, 6 months; 2, 6-7 years; Yes children with contrindication to pertussis component
DTaPHibIPV 3, 4.5, 6 months; 2 years; Yes
DTaPIPV 6-7 years; Yes
HepB birth; 1, 6 months; Yes or 12 years; +1, +6 months
Hib 3, 4.5, 6 months; 2 years; Yes children with contrindication to pertussis component
IPV 3, 4.5, 6 months; 2, 6-7 years; Yes children with contrindication to pertussis component or above Y14 if uncomplete vaccination
MMR 1, 13 years; Yes
Rotavirus from July 2014
Td 25 years; Yes every 10 years; children with contrindication to pertussis component and children > 14 years with uncomplete vaccination schedule
Tdap 15-17 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2014  2013-2014  2011-2013  2011-2013  2010-2011  2005-2010  2005-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 15  15  15  16  15  15  15 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 15  15  15  16  16  15  15 
Nº districts with DTP3 coverage >=80% number 15  15  15  15 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 11  10  11      15   
% of districts with MCV1 coverage >=95% From 0 to 100% 73  67  73      100   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100      100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.